This antibody specifically recognizes the extracellular domain of human CD134 and can be potentially used in cancer treatment.
Figure 1 Binding characteristics of mouse anti-human CD134 antibodies clone ACT35, clone 12H3, and clone 20E5 on PHA-M-stimulated human CD134 expressing T lymphocytes.
Figure 2 Binding of mouse anti-human CD134 antibodies clone 12H3 and clone 20E5 on PHA-M-stimulated human CD134 expressing CD4 T lymphocytes and CD8 T lymphocytes.
Figure 3 Dose effect of exposure to mouse anti-human CD134 antibodies clone 12H3 or clone 20E5, or to human OX40L on proliferation of PHA-M-stimulated human CD134 expressing T lymphocytes.
Figure 4 Effect of combining mouse anti-human CD134 antibodies clone 12H3 with human OX40L, or mouse anti-human CD134 antibodies clone 20E5 with human OX40L on proliferation of PHA-M-stimulated human CD134 expressing T lymphocytes.
Figure 5 Effect of exposure to mouse anti-human CD134 antibodies clone 12H3 or clone 20E5, or to human OX40L on proliferation of anti-human CD3/anti-human CD28 antibody stimulator beads-stimulated human CD134 expressing human regulatory T lymphocytes.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-633CL | Mouse Anti-TNFRSF4 Recombinant Antibody (TAB-633CL) | ELISA | Mouse IgG |
TAB-0877CL | Mouse Anti-TNFRSF4 Recombinant Antibody (TAB-0877CL) | FC | Mouse IgG |
TAB-0878CL | Mouse Anti-TNFRSF4 Recombinant Antibody (TAB-0878CL) | FC, Activ | Mouse IgG |
TAB-0887CL | Anti-Human TNFRSF4 Recombinant Antibody (20E5) | FuncS, FC | |
TAB-0877CL-S(P) | Mouse Anti-TNFRSF4 Recombinant Antibody; scFv Fragment (TAB-0877CL-S(P)) | FC | Mouse scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0873CL | Human Anti-TNFRSF4 Recombinant Antibody (TAB-0873CL) | FC, Inhib | Humanized antibody |
TAB-0876CL | Human Anti-TNFRSF4 Recombinant Antibody (TAB-0876CL) | ELISA, FuncS, FC | Humanized IgG |
TAB-0880CL | Human Anti-TNFRSF4 Recombinant Antibody (TAB-0880CL) | FC | Humanized antibody |
TAB-445CQ | Anti-Human TNFRSF4 Recombinant Antibody (Vonlerolizumab) | ELISA, IHC, FC, IP, IF, FuncS | IgG1, κ |
TAB-452CQ | Anti-Human TNFRSF4 Recombinant Antibody (Tavolixizumab) | ELISA, IHC, FC, IP, IF, FuncS | IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0874CL-S(P) | Mouse Anti-TNFRSF4 Recombinant Antibody; scFv Fragment (TAB-0874CL-S(P)) | ELISA, FC | Mouse scFv |
TAB-0879CL-S(P) | Mouse Anti-TNFRSF4 Recombinant Antibody; scFv Fragment (TAB-0879CL-S(P)) | FC | Mouse scFv |
TAB-0874CL-F(E) | Human Anti-TNFRSF4 Recombinant Antibody; Fab Fragment (TAB-0874CL-F(E)) | ELISA, FC | Chimeric (mouse/human) Fab |
TAB-0875CL-F(E) | Human Anti-TNFRSF4 Recombinant Antibody; Fab Fragment (TAB-0875CL-F(E)) | ELISA, FC | Chimeric (mouse/human) Fab |
TAB-0879CL-F(E) | Human Anti-TNFRSF4 Recombinant Antibody; Fab Fragment (TAB-0879CL-F(E)) | FC | Chimeric antibody (mouse/human) |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0881CL-F(E) | Human Anti-TNFRSF4 Recombinant Antibody; Fab Fragment (TAB-0881CL-F(E)) | ELISA, FC | Human Fab |
TAB-0882CL-F(E) | Human Anti-TNFRSF4 Recombinant Antibody; Fab Fragment (TAB-0882CL-F(E)) | ELISA, FC | Human Fab |
TAB-0883CL-F(E) | Human Anti-TNFRSF4 Recombinant Antibody; Fab Fragment (TAB-0883CL-F(E)) | ELISA, FC | Human Fab |
TAB-0884CL-F(E) | Human Anti-TNFRSF4 Recombinant Antibody; Fab Fragment (TAB-0884CL-F(E)) | ELISA, FC | Human Fab |
TAB-0885CL-F(E) | Human Anti-TNFRSF4 Recombinant Antibody; Fab Fragment (TAB-0885CL-F(E)) | ELISA, FC | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-2159CQ | Mouse Anti-Tnfrsf4 Recombinant Antibody (clone OX-40) | FC, Block, FC, IHC-Fr, IP | Mouse IgG2b, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-2160CQ | Rat Anti-Tnfrsf4 Recombinant Antibody (clone OX86) | FC, FuncS, IHC-Fr, Neut, WB | Rat IgG1, κ |
NEUT-2161CQ | Mouse Anti-TNFRSF4 Recombinant Antibody (clone CBL191) | FC, IHC, Neut | Mouse IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-3616 | Rabbit Anti-TNFRSF4 Recombinant Antibody (clone DS3616AB) | WB | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-102LC | Human Anti-TNFRSF4 Recombinant Antibody (clone MOXR0916) | ELISA, FC, WB, RIA, FuncS | Humanized IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-118CQ | Human Anti-TNFRSF4 Recombinant Antibody (clone YC147) | FuncS, FC, IHC | Human IgG1 |
HPAB-M0679-YC | Human Anti-TNFRSF4 Recombinant Antibody (clone M/YC-46) | ELISA, FuncS | Human IgG |
HPAB-N0276-YC | Mouse Anti-TNFRSF4 Recombinant Antibody (HPAB-N0276-YC) | ELISA, FC, Block | Mouse IgG |
HPAB-N0277-YC | Human Anti-TNFRSF4 Recombinant Antibody (HPAB-N0277-YC) | ELISA, FC, Block | Humanized IgG |
HPAB-N0278-YC | Human Anti-TNFRSF4 Recombinant Antibody (HPAB-N0278-YC) | FC, Inhib | Human IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0042-FY-F(E) | Human Anti-TNFRSF4 Recombinant Antibody (clone 106-222); Fab Fragment | Inhib | Humanized Fab |
HPAB-N0398-YC-F(E) | Human Anti-TNFRSF4 Recombinant Antibody; Fab Fragment (HPAB-N0398-YC-F(E)) | FC, Block | Human Fab |
HPAB-1632LY-F(E) | Human Anti-TNFRSF4 Recombinant Antibody; Fab Fragment (HPAB-1632LY-F(E)) | ELISA, FC | Human Fab |
HPAB-1633LY-F(E) | Human Anti-TNFRSF4 Recombinant Antibody; Fab Fragment (HPAB-1633LY-F(E)) | ELISA, FC | Human Fab |
HPAB-1634LY-F(E) | Human Anti-TNFRSF4 Recombinant Antibody; Fab Fragment (HPAB-1634LY-F(E)) | ELISA, FC | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-445CQ | Afuco™ Anti-TNFRSF4 ADCC Recombinant Antibody (Vonlerolizumab), ADCC Enhanced | ELISA, IHC, FC, IP, IF, FuncS | ADCC enhanced antibody |
AFC-TAB-452CQ | Afuco™ Anti-TNFRSF4 ADCC Recombinant Antibody (Tavolixizumab), ADCC Enhanced | ELISA, IHC, FC, IP, IF, FuncS | ADCC enhanced antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0189-WJ-S(P) | Human Anti-TNFRSF4 Recombinant Antibody; scFv Fragment (HPAB-0189-WJ-S(P)) | ELISA, WB, IP | Human scFv |
HPAB-3154LY-S(P) | Human Anti-TNFRSF4 Recombinant Antibody; scFv Fragment (HPAB-3154LY-S(P)) | ELISA | Human scFv |
HPAB-3155LY-S(P) | Human Anti-TNFRSF4 Recombinant Antibody; scFv Fragment (HPAB-3155LY-S(P)) | ELISA | Human scFv |
HPAB-3156LY-S(P) | Human Anti-TNFRSF4 Recombinant Antibody; scFv Fragment (HPAB-3156LY-S(P)) | ELISA | Human scFv |
HPAB-3157LY-S(P) | Human Anti-TNFRSF4 Recombinant Antibody; scFv Fragment (HPAB-3157LY-S(P)) | ELISA | Human scFv |
There are currently no Customer reviews or questions for TAB-0886CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.